5.49M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

BioSenic S. A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis.

Similar securities

Based on sector and market capitalization

Report issue